Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Titrated oxygen saturation targets in acute COPD exacerbation
2019-002498-80Phase 4Terminated
- Sponsor
- Mikkel Brabrand
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxygen in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Mikkel Brabrand. Primary endpoint: 30-day all-cause mortality. Started Aug 2019; status: terminated.
02
Drugs
oxygen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2019-002498-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002498-80.